Clinical Trials Logo

Skin Diseases clinical trials

View clinical trials related to Skin Diseases.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06237036 Completed - Skin Diseases Clinical Trials

Clinical Validation of AI-Based System for Continuous Remote Monitoring of Patient Severity

COVIDX_EVCDAO
Start date: March 3, 2022
Phase:
Study type: Observational

The goal of this observational prospective and analytical study is to evaluate the effectiveness of the device developed by Legit.Health in remotely monitoring the severity of chronic dermatologic pathologies. Secondly, to assess patient satisfaction with the device for remote monitoring. All this in patients diagnosed with any of the specified chronic dermatological conditions that meet the inclusion criteria. These patients are attended at the Dermatology Department of the Hospital Universitario de Torrejón. The study proceeded as follows: Patient Selection and Recruitment Visit The recruitment period spanned six months, during which investigators identified eligible patients. The Principal Investigator (PI) or designated collaborating investigators explained the study details to potential participants using the Patient Information Sheet. Patients had the opportunity to seek clarification on any aspects of the study. If a patient chose to participate, they provided informed consent and received a study code. Data collection commenced post-consent. During this initial visit, patients used the device under the supervision of the research team to complete questionnaires and capture photographs associated with their pathology. Subsequently, the patient autonomously and remotely continued the data collection process at home, as detailed in the following section. The device was provided at no cost to patients and the research team for the study's duration. Procedures Performed by the Patient at Home Completion of Questionnaires Patients independently reported on their condition from home, following instructions provided by the research team and the "Patient Information Guide" integrated into Legit.Health, in conjunction with photograph submissions. Every two months, patients completed the "Patient Satisfaction Questionnaire" addressing general user experience aspects. Additionally, they completed the System Usability Scale (SUS) Questionnaire at the same frequency Image capture Patients simultaneously took photographs of the affected areas while completing questionnaires through the app. These photographs were captured using the patient's smartphone from their homes in an autonomous manner. The frequency of photograph submission was determined by the consulting specialist. No specialized camera equipment was required; patients used the camera available on their smartphones. Patients then transmitted these photographs to the research team through a web app Both patients and members of the medical team possessed access credentials. The manufacturer did not have access to patient accounts or information. Data transfer and photograph storage adhered to the European Regulation 2016/679 of 27 April on the protection of natural persons with regard to the processing of personal data and the free movement of such data, as well as the Organic Law 3/2018 of 5 December on the Protection of Personal Data and guarantee of digital rights.

NCT ID: NCT06194487 Completed - Skin Condition Clinical Trials

Efficacy Evaluation of Collagen Drink Products

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

To assess MAXI Collagen drink on skin condition improvement

NCT ID: NCT06167226 Completed - Clinical trials for Rheumatoid Arthritis

Understanding Ayurveda Disease Conditions and Treatment Responses

Start date: December 29, 2021
Phase:
Study type: Observational

The goal of this observational study is to assess Prakriti & Vikriti in patients visiting OPD of IIISM department, SRM hospital. The main question[s] it aims to answer are: - To evaluate Prakriti & Vikriti of patients using Prakriti & Vikriti questionnaire and with digital devices - To correlate the determined Prakriti and Vikriti with the doctor's assessment along with clinical and biochemical parameters Participants will be advised to follow the treating physician's advice on medicines

NCT ID: NCT06073613 Completed - Psoriasis Clinical Trials

Periodontal Status in Patients With Chronic Skin Diseases

Start date: January 20, 2023
Phase:
Study type: Observational

Objective: This study aimed to evaluate and compare the periodontal status of chronic skin disease (CSD) patients with healthy controls. Material and method: 109 patients and 37 healthy subjects were included in this study. Parameters evaluated included bleeding on probing index (BOP), periodontal pocket depths (PPD), clinical attachment level (CAL), simplified debris index (DI), simplified calculus index (CI), and the presence of oral lesions. Clinical parameters were measured and compared in the two groups. The significant level was set at 0.05.

NCT ID: NCT06059417 Completed - Clinical trials for Dermatologic Conditions

Foam Tape Allergy a Sticky Situation

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

Foam tape is commonly used in the emergency department as a dressing over chest tubes owing to its occlusive and compressible properties. There is a paucity of data regarding the incidence of significant cutaneous reactions to this material. We conducted a prospective trial to evaluate the incidence of dermatitis following application of foam tape to the upper arm of a cohort of healthy volunteers.

NCT ID: NCT06035614 Completed - Autoimmune Diseases Clinical Trials

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Vitiligo is a auto immune that impact 2% of the global population, regardless from the phototype. Even though it affects patients in a physical way through loss of pigmentation, it is also impacting them on a mental/emotional way.11-12 Current treatments offer a symptomatic solution to patients, however the response rate can be low and results can be slow. Pediatric patients in vitiligo deserves special care as frequently (50%), the disease onset is before 20 years of age and, in 25% of the cases, it starts before the age of 10 years.13 Also, the current treatments for children are limited since it can involve pain and claustrophobia. The combination therapy of the study could offer a painless and easy treatment to follow. If the combination of those two therapies can fasten and improve the response rate, this could be a good option to treat this condition not only in children, but also for adults patients.

NCT ID: NCT06023303 Completed - Clinical trials for Dermatologic Conditions

Prospective Clinical Study to Assess Safety and to Collect Data on Radiofrequency Microneedling Device(s) For the Purpose of Evaluating Treatment on Skin

Start date: June 21, 2023
Phase: N/A
Study type: Interventional

The goal of the Radiofrequency microneedling devices (Potenza and Morpheus) used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.

NCT ID: NCT05988567 Completed - Skin Condition Clinical Trials

Efficacy Testing of Melon Oil Olive Pressed Candy Products

Start date: May 9, 2023
Phase: N/A
Study type: Interventional

To assess melon and oil olive pressed candy on skin condition improvement

NCT ID: NCT05988554 Completed - Skin Condition Clinical Trials

Efficacy Testing of Hibiscus Sabdariffa Extract and Collagen Products

Start date: June 5, 2023
Phase: N/A
Study type: Interventional

To assess Hibiscus sabdariffa extract and collagen products on skin condition improvement

NCT ID: NCT05908903 Completed - Sleep Disorder Clinical Trials

A Clinical Study on the Improvement of Sleep Quality, Skin Condition and Life Status After Taking Sleep Aid Drinks

Start date: July 9, 2022
Phase: N/A
Study type: Interventional

The main objective of the study is to observe changes in the subjects' sleep quality, skin condition and life status after 4 weeks of using a sleep aid drink (AOXMED Poria γ-aminobutyric acid drink). This is a single-center, randomized, double-blind, controlled, 4-week (28-day) clinical study conducted in Chinese healthy women aged 25-55 years old who were offered a sleep aid drink.